Company: RGBP
Filing Date: 2025-08-07
Form Type: 8-K
Source: 0001641172-25-022575
Chunk: 2

Company: Regen BioPharma Inc
Filing Date: 2025-08-07
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item
9.01 Financial Statements and Exhibits

  Exhibit      Description                                                            
      No.                                                                             
 ──────────────────────────────────────────────────────────────────────────────────────
     10.1      Convertible Promissory Note                                            
      104      Cover                                                                  

   2  

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                             REGEN                                                      
  Dated: August 7, 2025      By:                  /s/ David                             
                             Name:                David                                 
                             Title:               Chairman and Chief Executive Officer  

   3